Page last updated: 2024-08-23

4,4'-diisothiocyanostilbene-2,2'-disulfonic acid and Glycogen Storage Disease Type I

4,4'-diisothiocyanostilbene-2,2'-disulfonic acid has been researched along with Glycogen Storage Disease Type I in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bánhegyi, G; Benedetti, A; Burger, HJ; Capecchi, PL; Fulceri, R; Kardon, T; Leuzzi, R; Marcolongo, P1

Other Studies

1 other study(ies) available for 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid and Glycogen Storage Disease Type I

ArticleYear
Inhibition of microsomal glucose-6-phosphate transport in human neutrophils results in apoptosis: a potential explanation for neutrophil dysfunction in glycogen storage disease type 1b.
    Blood, 2003, Mar-15, Volume: 101, Issue:6

    Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Antioxidants; Apoptosis; Biological Transport; Cell Differentiation; Cyclohexanecarboxylic Acids; Enzyme Inhibitors; Ethylmaleimide; Glucose-6-Phosphate; Glycogen Storage Disease Type I; HL-60 Cells; Humans; Microsomes; NADPH Oxidases; Neutrophils

2003